Phase 3 hypoxic ischaemic encephalopathy Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Completed
Phase 3
PAEAN – Erythropoietin for hypoxic ischaemic encephalopathy in newborns
neonatal hypoxic ischaemic encephalopathy
University of Sydney300 enrolled21 locationsACTRN12614000669695
Recruiting
Phase 3
A trial to determine if cooling newborn infants at risk of brain damage improves outcome
Term infants with hypoxic ischaemic encephalopathy
Murdoch Children's Research Institute300 enrolled1 locationACTRN12606000036516